They found that the treated cancer cells had a significant reduction of HMMR expression, which inhibited the cell migration and invasion, and suppressed GBM cell growth both in vitro and in vivo.[248] Besides, siRNA was designed to target disease‐causing genes for HD and stroke treatment. Here, HMMR is linked to glioblastoma.